Contrave Extended-Release
NDC 51267-890, naltrexone hydrochloride and bupropion hydrochloride, tablet, extended release, from Nalpropion Pharmaceuticals LLC.
- Product NDC
- 51267-890
- Status
- Listed
- Labeler
- Nalpropion Pharmaceuticals LLC
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA200063
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/51267-890 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- NALTREXONE HYDROCHLORIDE8 mg/1
- BUPROPION HYDROCHLORIDE90 mg/1
Pharmacologic classes
Aminoketone [EPC]; Dopamine Uptake Inhibitors [MoA]; Increased Dopamine Activity [PE]; Increased Norepinephrine Activity [PE]; Norepinephrine Uptake Inhibitors [MoA]; Opioid Antagonist [EPC]; Opioid Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 51267-890-07 | 51267089007 | 7 TABLET, EXTENDED RELEASE in 1 BOTTLE (51267-890-07) |
| 51267-890-99 | 51267089099 | 120 TABLET, EXTENDED RELEASE in 1 BOTTLE (51267-890-99) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/485ff360-32c8-11df-928b-0002a5d5c51b
Use it
Look up 51267-890 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/51267-890 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 51267-890. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.